Clinical Trial Update: Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II

View source ↗

Summary

Completed update on the REVEAL II trial, a risk evaluation and education program for individuals with Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Alzheimer Disease | Status: COMPLETED